Le Lézard
Classified in: Health, Science and technology
Subject: AWD

Scientist.com Recognized as One of the Top 25 Biotechnology Companies of 2024


Online R&D marketplace makes exclusive list of top biotechs

SAN DIEGO, March 19, 2024 /PRNewswire-PRWeb/ -- Scientist.com, the pharma industry's leading R&D marketplace, today announced that it has been recognized as one of the Top 25 Biotechnology Companies of 2024 by The Healthcare Technology Report. The award highlight's the company's commitment to making it faster and cheaper to discover new cures for human diseases.

"Our growth is a testament to the hard work, dedication and visionary thinking of every member of our team, from our officers to our interns."?Kevin Lustig, PhD, CEO and Founder at Scientist.com.

"Our growth is a testament to the hard work, dedication and visionary thinking of every member of our team, from our officers to our interns," said Kevin Lustig, PhD, CEO and Founder at Scientist.com. "It also reflects the trust and collaborative spirit of the thousands of researchers and organizations that use our platform to drive their scientific research forward."

Since its founding inception in 2007, Scientist.com has enabled drug researchers to connect and collaborate seamlessly, reducing paperwork and speeding up the pace of innovation. The company believes that by empowering scientists with the most innovative tools and technologies it can help usher in a new era of breakthroughs that will ultimately lead to an end to disease as we know it.

Scientist.com was previously named America's 11th Most Innovative Company by Fortune in 2023; the "Overall BioPharma Solution of the Year" in the 2022 BioTech Breakthrough Awards; and was added to Inc. magazine's "Honor Roll" for being one of the fastest-growing private companies in America five consecutive years, from 2017-2021, ranking as high as #9.

For the full list of The Healthcare Technology Report's "Top 25 Biotechnology Companies of 2024," visit https://thehealthcaretechnologyreport.com/the-top-25-biotechnology-companies-of-2024/

About Scientist.com
Scientist.com is a privately held San Diego-based company on a mission to make it faster and cheaper to discover new medicines. At its heart is an AI-powered marketplace that helps drug researchers use innovative technologies to rapidly translate their ideas into actionable data. Through Scientist.com, scientists communicate directly with research experts at over 4,000 global laboratories to design and execute complex research experiments. Visit scientist.com to learn more.

Join Scientist.com on social media: LinkedIn, Twitter, YouTube, Facebook and Instagram

Media Contact

Sean Preci, Scientist.com, 877-644-044, [email protected], www.scientist.com

SOURCE Scientist.com


These press releases may also interest you

at 08:30
Toitures Hogue's commitment to providing its employees with a structured, professional working environment that guarantees complete safety in the workplace, both on the job and on the job site, has just been awarded its renewed ISO 45001...

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...



News published on and distributed by: